Comparison between Metro Brands IPO and Supriya Lifescience IPO.
Metro Brands IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Supriya Lifescience IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Metro Brands IPO is up to ₹1,367.51 Cr whereas the issue size of the Supriya Lifescience IPO is up to ₹700.00 Cr. The final issue price of Metro Brands IPO is ₹500.00 per share and of Supriya Lifescience IPO is ₹274.00 per share.
| Metro Brands IPO | Supriya Lifescience IPO | |
|---|---|---|
| Face Value | ₹5 per share | ₹2 per share |
| Issue Price (Lower) | ₹485.00 per share | ₹265.00 per share |
| Issue Price (Upper) | ₹500.00 per share | ₹274.00 per share |
| Issue Price (Final) | ₹500.00 per share | ₹274.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 30 shares | 54 shares |
| Fresh Issue Size | 59,00,000 shares | 72,99,270 shares |
| Fresh Issue Size (Amount) | up to ₹295.00 Cr | up to ₹200.00 Cr |
| OFS Issue Size | 2,14,50,100 shares | 1,82,48,175 shares |
| OFS Issue Size (Amount) | up to ₹1,072.51 Cr | up to ₹500.00 Cr |
| Issue Size Total | 2,73,50,100 shares | 2,55,47,445 shares |
| Issue Size Total (Amount) | up to ₹1,367.51 Cr | up to ₹700.00 Cr |
Metro Brands IPO opens on Dec 10, 2021, while Supriya Lifescience IPO opens on Dec 16, 2021. The closing date of Metro Brands IPO and Supriya Lifescience IPO is Dec 14, 2021, and Dec 20, 2021, respectively.
| Metro Brands IPO | Supriya Lifescience IPO | |
|---|---|---|
| Anchor Bid Date | Dec 09, 2021 | Dec 15, 2021 |
| Issue Open | Dec 10, 2021 | Dec 16, 2021 |
| Issue Close | Dec 14, 2021 | Dec 20, 2021 |
| Basis Of Allotment (Tentative) | Dec 17, 2021 | Dec 23, 2021 |
| Initiation of Refunds (Tentative) | Dec 20, 2021 | Dec 24, 2021 |
| Credit of Share (Tentative) | Dec 21, 2021 | Dec 27, 2021 |
| Listing date (Tentative) | Dec 22, 2021 | Dec 28, 2021 |
| Anchor Lockin End date 1 | Jan 16, 2022 | Jan 22, 2022 |
| Anchor Lockin End date 2 | Mar 17, 2022 | Mar 23, 2022 |
Metro Brands IPO P/E ratio is , as compared to Supriya Lifescience IPO P/E ratio of .
| Metro Brands IPO | Supriya Lifescience IPO | |||||
|---|---|---|---|---|---|---|
| Financials | Company Financials ()
| Company Financials ()
| ||||
| Promoter Shareholding (Pre-Issue) | 84.02 | 99.98 | ||||
| Promoter Shareholding (Post-Issue) | 74.27 | 68.24 | ||||
| P/E Ratio | ||||||
| Market Cap | ₹13575.37 Cr. | ₹700.00 Cr. | ||||
| ROE | ||||||
| ROCE | ||||||
| Debt/Equity | ||||||
| EPS | ||||||
| RoNW |
In the Metro Brands IPO Retail Individual Investors (RII) are offered 95,72,535 shares while in Supriya Lifescience IPO retail investors are offered 95,72,535 shares. Qualified Institutional Buyers (QIB) are offered 54,70,020 shares in Metro Brands IPO and 76,64,234 shares in Supriya Lifescience IPO.
| Metro Brands IPO | Supriya Lifescience IPO | |
|---|---|---|
| Anchor Investor Reservation | 82,05,030 shares | 1,14,96,351 shares |
| Market Maker Reservation | ||
| QIB | 54,70,020 shares | 76,64,234 shares |
| NII | 41,02,515 shares | 38,32,116 shares |
| RII | 95,72,535 shares | 25,54,744 shares |
| Employee | ||
| Others | ||
| Total | 2,73,50,100 shares | 2,55,47,445 shares |
Metro Brands IPO subscribed 3.64x in total, whereas Supriya Lifescience IPO subscribed 71.51x.
| Metro Brands IPO | Supriya Lifescience IPO | |
|---|---|---|
| QIB (times) | 8.49x | 31.83x |
| NII (times) | 3.02x | 161.22x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 1.13x | 56.01x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 3.64x | 71.51x |
